Because of the more reasonable proportion of positive cells in 5 EOC cell lines than in other common CSC biomarkers, such as CD44, CD117 and CD133 (Supplementary Table 2), CDC50A might be a candidate biomarker of epithelial ovarian cancer-initiating cells. This evidence concerns the gene KIT and ovarian carcinoma.